Zhang Yu, Zhao Hong, Ji Shi-Bo, Xing Hui-Chun
Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Peking University Ditan Teaching Hospital, Beijing 100015, China.
Center of Liver Diseases Division 1, Beijing Ditan Hospital, Capital Medical University, Peking University Ditan Teaching Hospital, Beijing 100015, China.
World J Hepatol. 2024 Dec 27;16(12):1441-1449. doi: 10.4254/wjh.v16.i12.1441.
The incidence of () infection in patients with cirrhosis has been increasing over recent years, posing certain difficulties in clinical treatment.
To analyze the clinical features of patients with liver cirrhosis and identify the risk factors to help the early diagnosis and treatment of these diseases.
Clinical data and laboratory tests were collected from 72 patients with cirrhosis confirmed by secretion or blood culture of infection at Beijing Ditan Hospital, Capital Medical University, between May 2016 and October 2018. Data from hospitalized patients with liver cirrhosis and infections, including age, sex, antimicrobial use, length of stay, site of infection, distribution of pathogenic bacteria, complications, invasive operations, laboratory indicators, treatment, and clinical regression, were extracted and retrospectively analyzed. Clinical data and biochemical values were included in the multivariate logistic regression analysis.
A total of 52 men and 20 women, with an age range from 29 to 85 years and an average age of 57.7 ± 12.54, were analyzed. The incidence of hospital infection in patients with cirrhosis was approximately 19.44%. The most common the infection site was the bloodstream, followed by the respiratory tract, abdominal cavity, and biliary tract. Risk factors for infection were old age, long hospital stays, gastrointestinal bleeding, and low serum albumin levels, while prophylactic antibiotics were protective factors. The multivariate analysis suggested that other infections, chronic diseases, and invasive procedures were independent factors.
In clinical practice, the length of hospital stays should be shortened as much as possible, invasive operations should be reduced, antibiotics should be rationally used, and the patients' liver function should be timely improved. This is of great significance for reducing the incidence of hospital infection.
近年来,肝硬化患者中()感染的发生率不断上升,给临床治疗带来一定困难。
分析肝硬化患者的临床特征,确定危险因素,以助于这些疾病的早期诊断和治疗。
收集2016年5月至2018年10月在首都医科大学附属北京地坛医院确诊为()感染且经分泌物或血培养证实的72例肝硬化患者的临床资料和实验室检查结果。提取并回顾性分析肝硬化合并()感染住院患者的数据,包括年龄、性别、抗菌药物使用情况、住院时间、感染部位、病原菌分布、并发症、侵入性操作、实验室指标、治疗及临床转归。临床资料和生化值纳入多因素logistic回归分析。
共分析了52例男性和20例女性患者,年龄范围为29至85岁,平均年龄为57.7±12.54岁。肝硬化患者医院()感染的发生率约为19.44%。最常见的感染部位是血流,其次是呼吸道、腹腔和胆道。感染的危险因素为高龄、住院时间长、胃肠道出血和血清白蛋白水平低,而预防性使用抗生素是保护因素。多因素分析提示其他感染、慢性疾病和侵入性操作是独立因素。
在临床实践中,应尽可能缩短住院时间,减少侵入性操作,合理使用抗生素,并及时改善患者肝功能。这对于降低医院感染发生率具有重要意义。